Abcuro Secures $200M Series C to Advance Ulviprubart for IBM
Key Highlights Abcuro raises $200M in Series C funding led by New Enterprise Associates (NEA) with participation from…
Browsing Tag
RA Capital Management
12 posts
Trace Neuroscience Launches with $101M to Target ALS and Neurodegenerative Diseases
Key Highlights $101M Series A funding led by Third Rock Ventures and others, supporting ALS and neurodegenerative therapies. UNC13A-focused…
Vesta Healthcare Closes $65M Series C Funding with New Debt Financing
Key Highlights Vesta Healthcare raises $65M in Series C round led by RA Capital Management. Debt financing provided by…
Navigator Medicines Secures $100M Series A Financing and In-Licenses NAV-240
Key Highlights Navigator Medicines closes $100M Series A financing co-led by RA Capital Management and Forbion. In-licenses NAV-240 and…
Halda Therapeutics Secures $126M to Advance Novel RIPTAC Cancer Therapies
Key Highlights Halda Therapeutics raises $126M in Series B extension, total $202M funding to date. Proceeds will advance…
IDRx Completes $120M Series B Financing to Advance GIST Treatment
Key Highlights $120 million Series B financing led by RA Capital Management, Commodore Capital, and Blackstone Multi-Asset Investing. Proceeds…
Mariana Oncology Acquired by Novartis for $1.75 Billion
Key Highlights $1 billion upfront, with up to $750 million in potential milestones for Mariana Oncology’s acquisition. Mariana Oncology’s…
Asher Bio Secures $55M in Series C Funding for Cancer Therapy
Key Highlights $55 million raised in Series C financing to advance AB248, a novel cancer immunotherapy. New investors include AstraZeneca…
Capstan Therapeutics Secures $175M in Series B
Key Highlights $175M Series B financing led by RA Capital Management with broad investor participation. Funds to advance CPTX2309, Capstan’s…
FogPharma Secures $145M Series E for Cancer Breakthrough
Key Highlights $145 million Series E funding led by Nextech Invest, with contributions from top investors including RA Capital…